Background Little evidence has been available to support the use of thiazide diuretics to
treat hypertension in patients with advanced chronic kidney disease. Methods We randomly …

Hypertension is very common and remains often poorly controlled in patients with chronic
kidney disease (CKD). Accurate blood pressure (BP) measurement is the essential first step …

Abstract Purpose of Review To explore the prevalence, treatment particularities, and
research agenda in the management of resistant hypertension among patients with chronic …

Objective: Finerenone is a selective nonsteroidal mineralocorticoid receptor antagonist with
a short half-life. Its effects on cardiorenal outcomes were thought to be mediated primarily …

Background Chronic kidney disease (CKD) is an important cause of morbidity and mortality
worldwide. There is a lack of information on epidemiology and progression of CKD in low …

Abstract BACKGROUND Ocedurenone (KBP-5074), a nonsteroidal mineralocorticoid
receptor antagonist, is documented to lower blood pressure in patients with stage 3b/4 …

Objectives Increasing evidence suggests that mitochondrial dysfunction is the key driver of
angiotensin II (Ang II)‐induced kidney injury. This study was designed to investigate whether …

Introduction The uptake of the Kidney Disease: Improving Global Outcomes (KDIGO) 2012
chronic kidney disease (CKD) Guideline is not fully described in real-world nephrology …

Background Chronic kidney disease (CKD) is common but heterogenous and is associated
with multiple adverse outcomes. The National Unified Renal Translational Research …

Populations in the high-income countries of Western Europe are aging due to increased life
expectancy. As the prevalence of diabetes and obesity has increased, so has the burden of …